Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters
Mike Grady , Hilary Cameron , Elizabeth Holt
Exploration of Endocrine and Metabolic Diseases ›› 2024, Vol. 1 ›› Issue (4) : 167 -76.
Aim: Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and guideline-recommended glycemic targets achieved in PwGDM using a diabetes app with a family of Bluetooth® connected BGMs. Methods: Anonymized glucose and app analytics data from 26,382 PwGDM were sourced from a server. Data from their first 7-days using the app with connected BGMs was compared to 7-days prior to a 10-week timepoint. Results: Percent fasting readings in range (RIR, < 5.3 mmol/L) improved by +20.3 percentage points in the overall population. Improved glucose RIR (3.5 to 7.8 mmol/L) (+8.3 percentage points), mean blood glucose (BG, –0.59 mmol/L), and fasting RIR (+33.2 percentage points) were observed in those with baseline mean BG ≥ 6.1 mmol/L. Improvements in mean BG of –0.32 to –2.36 mmol/L, and RIR of +3.0 to +38.3 percentage points correlated with higher baseline mean BG ≥ 6.1 to ≥ 7.8 mmol/L. Only 58.5% of PwGDM with baseline mean BG ≥ 6.1 mmol/L had > 80% RIR at baseline, which improved to 79.5% at 10 weeks. PwGDM averaged 17 app sessions and 90 minutes per week on the app. Conclusions: PwGDM engaged with the diabetes app and connected BGM, facilitating attainment of glycemic targets, an especially important outcome for those with higher mean glucose at baseline.
Gestational diabetes / real world evidence / diabetes mobile app / connected blood glucose meters
| [1] |
Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, |
| [2] |
|
| [3] |
HAPO Study Cooperative Research Group; |
| [4] |
American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024. Diabetes Care. 2024; 47: S282-94. |
| [5] |
|
| [6] |
Murphy HR, Howgate C, O’Keefe J, Myers J, Morgan M, Coleman MA, |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
Setford S, Smith A, McColl D, Grady M, Koria K, Cameron H. Evaluation of the performance of the OneTouch Select® Plus blood glucose test system against ISO 15197:2013. Expert Rev Med Devices. 2015;12:771-81. |
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
Pigato F, Candido R, Zanette G, Zamagni G, |
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
/
| 〈 |
|
〉 |